Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: Expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells

Journal of Neurosurgery

Volumn 94, Issue 6, 2001, Pages 961-971

  Pallini, Roberto ^b   Pierconti, Francesco ^b   Falchetti, Maria Laura ^b   D'Arcangelo, Daniela ^b   Fernandez, Eduardo ^b   Maira, Giulio ^b   D'Ambrosio, Ettore ^b   Larocca, Luigi Maria ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

Astrocytoma; Human telomerase reverse transcriptase; In situ hybridization; Tumor angiogenesis

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; ASTROCYTOMA; BRAIN INFARCTION; CANCER GRADING; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROBE; TELOMERE; TUMOR VASCULARIZATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0034859505     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2001.94.6.0961     Document Type: Article

References (116)

1. Vascular smooth muscle cell proliferation in arterioles of the human endometrium
2. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma
3. Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis
4. Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells
5. Telomerase activity: A biomarker of cell proliferation, not malignant transformation
6. Extension of lifespan by introduction of telomerase into normal human cells
7. Tumor angiogenesis: The role of oncogenes and tumor suppressor genes
8. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
9. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma
10. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors
11. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma
12. Telomerase expression in gliomas including the nonastrocytic tumors
13. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase
14. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
15. Differential telomerase expression in human primary intracranial tumors
16. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging
17. Actions of heparin that may affect the malignant process
18. Induction of telomerase activity in v-myc transformed avian cells
19. Telomerase expression in intracranial tumours: Prognostic potential for malignant gliomas and meningiomas
20. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras
21. Tumor angiogenesis: Therapeutic implications
22. What is the evidence that tumors are angiogenesis dependent?
23. Blood vessel formation: What is its molecular basis?
24. Induction of angiogenesis during the transition from hyperplasia to neoplasia
25. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium
26. Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous-cell carcinoma
27. Endometrial endothelial cell proliferation during the menstrual cycle
28. Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas
29. Glutathione S-transferases and cytochrome P450 detoxifying enzyme distribution in human cerebral glioma
30. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
31. Association of angiogenesis in lymph node metastases with outcome of breast cancer
32. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes
33. Telomere loss: Mitotic clock or genetic time bomb?
34. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors
35. Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation
36. Increased endothelial expression of transglutaminase in glioblastomas
37. Telomerase activity and alterations in telomere length in human brain tumors
38. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
39. Tumor angiogenesis in advanced stage ovarian carcinoma
40. Refining the telomere-telomerase hypothesis of aging and cancer
41. Telomerase activity in normal human endothelial cells
42. Correlation of clinical features and telomerase activity in human gliomas
43. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
44. Antiangiogenesis treatment for gliomas: Transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo
45. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors
46. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: A review
47. Tumor progression and angiogenesis: Cathepsin B & Co
48. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
49. Specific association of human telomerase activity with immortal cells and cancer
50. Glioblastoma
51. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labeling
52. Vascular endothelial growth factor is implicated in early invasion in cervical cancer
53. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
54. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
55. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
56. Telomerase activity in human brain tumours
57. Espressione in situ della telomerase reverse transcriptase (hTERT) nei glioblastomi multiformi
58. Telomerase activity in human gliomas
59. Microvessel density is a prognostic indicator for patients with astroglial brain tumors
60. Studies of the molecular mechanisms in the regulation of telomerase activity
61. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes
62. Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inlet
63. Detection of growth hormone-producing cells in human thymus by immunohistochemistry and non-radioactive in situ hybridization
64. Cellular targets of exogenous tumour necrosis factor-alpha (TNFα) in human gliomas
65. The transforming growth factor-β family
66. Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed gliomasarcoma
67. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization
68. Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas
69. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
70. Telomerase catalytic subunit homologs from fission yeast and human
71. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer
72. The significant role of telomerase activity in human brain tumors
73. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
74. Neovascularization in clinical stage. A testicular germ cell tumor: Prediction of metastatic disease
75. Do telomerase antagonists represent a novel anti-cancer strategy?
76. Mechanisms of angiogenesis in the brain
77. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF-receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
78. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
79. A human vascular endothelial cell model to study angiogenesis and tumorigenesis
80. Mechanisms of angiogenesis
81. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
82. Induction of vascular endothelial growth factor by tumor necrosis factor α in human glioma cells. Possible roles of SP-1
83. Tumor angiogenesis and rectal carcinoma
84. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas
85. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells
86. A survey of telomerase activity in human cancer
87. Cellular senescence: Mitotic clock or culture shock?
88. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
89. Induction of transformational changes in normal endothelial cells by cultured human astocytoma cells
90. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression
91. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
92. Correlation of endothelin-1 and transforming growth factor-β 1 with malignancy and vascularity in human gliomas
93. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
94. Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation
95. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer
96. Bone marrow angiogenesis and progression of multiple myeloma
97. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended life span
98. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study
99. Myc activates telomerase
100. Origin of concatemeric DNA
101. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
102. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
103. Telomerase activity in microdissected human gliomas
104. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: The key to angiogenesis?
105. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
106. Tumor angiogenesis as a prognostic factor in oral cavity tumors
107. Direct activation of TERT transcription by c-myc
108. Tumor angiogenesis in human lung adenocarcinoma
109. Vasculogenesis, angiogenesis and growth factors: Ephrins enter the fray at the border
110. Human endothelial cell life extension by telomerase expression
111. Telomerase activity in normal human epithelial cells
112. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro
113. Structure, function, and replication of Saccharomyces cerevisiae telomeres